<DOC>
	<DOCNO>NCT02304627</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate effect food pharmacokinetics ( exposure trial drug body ) NNC0123-0000-0338 tablet formulation healthy subject .</brief_summary>
	<brief_title>Effect Food Pharmacokinetics NNC0123-0000-0338 Tablet Formulation Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 1864 year ( inclusive ) time sign informed consent Body mass index 18.528.0 kg/m^2 ( inclusive ) Subject consider healthy base medical history , physical examination , result vital sign , electrocardiogram clinical laboratory test perform screen visit , judge investigator Known suspect hypersensitivity trial product relate product Previous participation trial . Participation define informed consent Presence clinically significant acute chronic gastrointestinal symptom ( e.g . nausea , vomit , heartburn diarrhoea ) within 2 week prior first dose , judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>